SIGNS – Trademark Portfolio

Entity Type: 34

SIGNS holds 15 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 15 filings in this category. The portfolio also extends into Class 1 (Chemicals) across 3 Nice Classification classes. Currently, 9 trademarks are registered and 6 are pending. Notable registered marks include SIGNS, NOCLEG, SECUREBUNNY, MONTGOMERINE, and SECURECATTLE.

Quartier Salignan

F-84400 APT

15 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

SIGNS's trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

5
Pharmaceuticals (15 filings)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

1
Chemicals (1 filing)

Chemical products for industry, science, photography, agriculture, horticulture and forestry

3
Cosmetics & Cleaning (1 filing)

Bleaching preparations and other substances for laundry use; cleaning, polishing, scouring

Frequently Asked Questions

How many trademarks does SIGNS have?

SIGNS has 15 U.S. trademarks filed with the USPTO. Of these, 9 registered, 6 pending.

What trademark classes does SIGNS file in?

SIGNS files trademarks across 3 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 1 (Chemicals), Class 3 (Cosmetics & Cleaning). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.

What are SIGNS's most well-known trademarks?

SIGNS's registered trademark portfolio includes well-known marks such as SIGNS, NOCLEG, SECUREBUNNY, MONTGOMERINE, and SECURECATTLE. These are among 9 currently registered trademarks in the portfolio.

What is SIGNS's trademark registration success rate?

SIGNS has a 100% trademark registration rate, with 9 out of 9 resolved applications resulting in successful registration. Currently, 6 applications are pending review.